0001104659-21-103418.txt : 20210811 0001104659-21-103418.hdr.sgml : 20210811 20210811151623 ACCESSION NUMBER: 0001104659-21-103418 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210811 DATE AS OF CHANGE: 20210811 EFFECTIVENESS DATE: 20210811 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Serimmune Inc. CENTRAL INDEX KEY: 0001693808 IRS NUMBER: 464761259 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-409629 FILM NUMBER: 211163167 BUSINESS ADDRESS: STREET 1: 917 N. PATTERSON AVE. CITY: SANTA BARBARA STATE: CA ZIP: 93111 BUSINESS PHONE: (805) 451-5083 MAIL ADDRESS: STREET 1: 917 N. PATTERSON AVE. CITY: SANTA BARBARA STATE: CA ZIP: 93111 D 1 primary_doc.xml X0708 D LIVE 0001693808 Serimmune Inc. 150 CASTILIAN DRIVE, SUITE 100 GOLETA CA CALIFORNIA 93117 (805) 650-5229 DELAWARE None None Corporation true Noah Nasser 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Executive Officer Director Patrick Daugherty c/o Serimmune Inc. 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director Bill Welch c/o Serimmune Inc. 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director John Shon 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Executive Officer Kristin Loomis 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director Nicholas Naclerio c/o Serimmune Inc. 150 Castilian Drive, Suite 100 Goleta CA CALIFORNIA 93117 Director Biotechnology Decline to Disclose 06b false 2021-07-02 false true true Convertible Promissory Notes and the Equity Securities issuable upon conversion of such Notes false 0 7000000 4362861 2637139 false 3 0 0 0 false Serimmune Inc. /s/ Noah Nasser Noah Nasser Chief Executive Officer 2021-08-10